Andrew Radonjic – Managing Director – Venture Minerals (ASX:VMS) is dedicated to discovering and developing world-class mineral deposits to meet global demand for critical minerals vital to the green energy transition.
Copyright 2024 – Finance News Network
10 Sep 2019 - Cashwerkz Limited (ASX:CWZ) Director, John Nantes talks FY19 results and outlook, including growth in distribution through adviser platforms, neo-banks and new functionality.
05 Oct 2022 - QX Resources Limited (ASX:QXR) Managing Director Stephen Promnitz discusses what brought him to QXR, and the company's assets and development stage.
10 Oct 2023 - Alex Hanly - CEO - Lithium Universe (ASX:LU7) objective is to construct a Lithium Project in Québec with utmost speed, and to assist Canada facilitate the transition towards cleaner energy.
21 Mar 2023 - Centuria Capital Group Limited (ASX:CNI) Joint CEO John McBain discusses the rising interest rate environment, the company's expansion into the healthcare and agricultural sectors, the acquisition of Primewest, and possible future M&A opportunities.
01 Jun 2020 - NetLinkz Limited (ASX:NET) Executive Chairman & CEO James Tsiolis provides an update on the company's suite of networking solutions, the market opportunity and progress with partners.
16 Sep 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams discusses the company’s high-grade exploration results from its northern NSW project, plus how it’s poised to benefit from the rise of ‘critical minerals’ designation.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
16 Aug 2023 - Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
19 Sep 2022 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan discusses the advantages of the company's sodium alumina solid state batteries over lithium-ion batteries, and the roadmap ahead to commercialisation.
04 Nov 2022 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses the company's new agreement with Case Western Reserve University.